Skip to main content

Expression of Vascular Endothelial Growth Factor Receptor-3 (Vegfr-3) in the Conjunctiva-A Potential Link Between Lymphangiogenesis and Leukocyte Trafficking on the Ocular Surface

  • Chapter
Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 506))

Abstract

Although the lymphatic system penetrates most tissues as a dense network, it has received relatively little attention outside the fields of immunology and vascular biology. The normal cornea is devoid of blood and lymphatic vessels, but a number of corneal stimuli such as contact lens wear, infection, surgical invasion or burns can induce penetration of new vessels from the limbus and conjunctiva into the cornea. The process of growth and development of new blood vessels from preexisting ones is termed angiogenesis, and in the case of lymphatic vessels, lymphangiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H.B. Collin. Corneal lymphatics in alloxan vascularized rabbit eyes.Invest Ophthalmol Vis Sci 5:1 (1966).

    Google Scholar 

  2. H.B. Collin. Endothelial cell lined lymphatics in vascularized rabbit cornea.Invest Ophthalmol Vis Sci, 5:337 (1966).

    CAS  Google Scholar 

  3. H.B. Collin. The fine structure of growing corneal lymphatic vessels.J Pathol104:99 (1971).

    Article  CAS  PubMed  Google Scholar 

  4. P.C. Burger, and G.K. Klintworth. Autoradiographic study of corneal neovascularization induced by chemical cautery.Lab Invest45:328 (1981).

    CAS  PubMed  Google Scholar 

  5. H.B. Collin. Lymphatic drainage of ’31I-albumin from the vascularized cornea.Invest Ophthalmol Vis Sci9:146 (1970).

    CAS  Google Scholar 

  6. M. Fine, and M. Stein. The role of corneal vascularization in human graft rejection.Corneal graft failure ciba foundation symposium.Amsterdam, Holland: Assoc. Scientific Publishers; 1973:193.

    Google Scholar 

  7. S. Yamagami, and M.R. Dana. The critical role of draining lymph nodes in corneal allosensitization.Invest Ophthalmol Vis Sci42:1293 (2001).

    CAS  PubMed  Google Scholar 

  8. D.R. Senger, S.S. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.Science219:983 (1983).

    Article  CAS  PubMed  Google Scholar 

  9. N. Ferrera, and T. Davis-Smyth. The biology of vascular endothelial growth factor.Endocrine Rev18:4 (1997).

    Article  Google Scholar 

  10. H.F. Dvorak, L.F. Brown, M. Detmar, and A.M. Dvorak. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. AmJ Pathol146:1029 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, and K. Alitalo. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.EMBO J15:290 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. E. Kukk, A. Lymboussaki, S. Taira, A. Kaipainen, M. Jeltsch, V. Joukov, and K. Alitalo. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.Development122:3829 (1996).

    CAS  PubMed  Google Scholar 

  13. M.G. Achen, M. Jeltsch, E. Kukk, T. Mäkinen, A. Vitali, A.F. Wilks, K. Alitalo, and S.A. Stacker. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (FLK1) and VEGF receptor 3 (FLT4).Proc Natl Acad Sci USA95:548 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. J. Lee, A. Gray, J. Yuan, S.-M. Luoh, H. Avraham, and W.I. Wood. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4.Proc Natl Acad Sci USA93:1988 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Y. Cao, P. Linden, J. Farnebo, R. Cao, A. Eriksson, V. Kumar, J.-H. Qi, L. Claesson-Welsh, and K. Alitalo. Vascular endothelial growth factor C induces angiogenesisin vivo. Proc Natl Acad Sci USA95:14389 (1998).

    Article  CAS  PubMed  Google Scholar 

  16. M. Jeltsch, A. Kaipainen, V. Joukov, X. Meng, M. Lakso, H. Rauvala, M. Swartz, D. Fukumura, R.K. Jain, and K. Alitalo. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.Science276:1423 (1997).

    Article  CAS  PubMed  Google Scholar 

  17. S.J. Oh, M.M. Jeltsch, R. Birkenhäger, J.E.G. McCarthy, H.A. Weich, B. Christ, K. Alitalo, and J. Wilting. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.Dey Biol188:96 (1997).

    Article  CAS  Google Scholar 

  18. V. Joukov, T. Sorsa, V. Kumar, M. Jeltsch, L. Claesson-Welsh, Y. Cao, O. Saksela, N. Kalkkinen, and K. Alitalo. Proteolytic processing regulates receptor specificity and activity of VEGF-C.EMBO J16:3898 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. K. Pajusola, O. Aprelikova, G. Pelicci, H. Weich, L. Claesson-Welsh, and K. Alitalo. Signalling properties of Flt4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.Oncogene9:3545 (1994).

    CAS  PubMed  Google Scholar 

  20. B. Olofsson, M. Jeltsch, U. Eriksson, and K. Alitalo. Current biology of VEGF-B and VEGF-C.Curr Opin Biotechnol10:528 (1999).

    Article  CAS  PubMed  Google Scholar 

  21. A. Kaipainen, J. Korhonen, T. Mustonen, V.W.M. van Hinsbergh, G.H. Fang, D.J. Dumont, M. Breitman, and K. Alitalo. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.Proc Natl Acad Sci USA92:3566 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. G. Smith, D. McLeod, D. Foreman, and M. Boulton. Immunolocalisation of the VEGF receptors Flt-1, KDR, and Flt-4 in diabetic retinopathy.Br J Ophthalmol83:486 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. T. Mimura, S. Amano, T. Usui, Y. Kaji, T. Oshika, and Y. Ishii. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.Exp Eye Res72:71 (2001).

    Article  CAS  PubMed  Google Scholar 

  24. M.R. Dana, and J.W. Streilein. Loss and restoration of immune privilege in eyes with corneal neovascularization.Invest Ophthalmol Vis Sci37:2485 (1996).

    CAS  PubMed  Google Scholar 

  25. A. Lymboussaki, T.A. Partanen, B. Olofsson, J. Thomas-Crusells, C.D.M. Fletcher, R.M.W. de Waal, A. Kaipainen, and K. Alitalo. Expression of the vascular endothelial growth factor C receptor VEGFR3 in lymphatic endothelium of the skin and in vascular tumors.Am J Pathol153:395 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. L. Jussila, R. Valtola, T.A. Partanen, P. Salven, P. Heikkilä, M.T. Matikainen, R. Renkonen, A. Kaipainen, M. Detmar, E. Tschachler, R. Alitalo, and K. Alitalo. Lymphatic endothelium and kaposi’s sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.Cancer Res58:1599 (1998).

    CAS  PubMed  Google Scholar 

  27. J. Wilting, A. Eichmann, and B. Christ. Expression of the avian VEGF receptor homologuesqueklandquek2in blood-vascular and lymphatic endothelial and non-endothelial cells during quail embryonic development.Cell Tiss Res, 288:207 (1997).

    Article  CAS  Google Scholar 

  28. L. Marconcini, S. Marchio, L. Morbidelli, E. Cartocci, A. Albini, M. Ziche, F. Bussolino, and S. Oliviero. C-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesisin vivoand in vitro.Proc Natl Acad Sci USA, 96:9671 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. B. Witzenbichler, T. Asahara, T. Murohara, M. Silver, I. Spyridopoulos, M. Magner, N. Principe, M. Kearney, J.S. Hu, and J.M. Isner. Vascular endothelial growth factor-c (vegf-c/vegf-2) promotes angiogenesis in the setting of tissue ischemia. Am JPathol153:381 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. D. Chilov, E. Kukk, S. Taira, M. Jeltsch, J. Kaukonen, A. Palotie, V. Joukov, and K. Alitalo. Genomic organization of human and mouse genes for vascular endothelial growth factor C.J Biol Chem272:25176 (1997).

    Article  CAS  PubMed  Google Scholar 

  31. C. Caux, B. Vanbervliet, C. Massacrier, C. Dezutter-DambuyantB.de Saint-Vis, C. Jacques, K. Yoneda, S. Imamura, D. Schmitz, and J. Banchereau. CD34’ hematopoietic progenitors from human cord blood differentiate along two independant dendritic cell pathways in response to GM-CSF + TNFa. J Exp Med, 184:695 (1996).

    Article  CAS  PubMed  Google Scholar 

  32. C. Caux, C. Massacrier, B. Vanbervliet, B. Dubois, I. Durand, M. Cella, A. Lanzavecchia, and J. Banchereau. CD34’ hematopoietic progenitors from human cord blood differentiate along two independant dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor cc II. Functional analysis.Blood90:1458 (1997).

    CAS  PubMed  Google Scholar 

  33. S. MarchiĂł, L. Prima, M. Pagano, G. Palestro, A. Albini, T. Veikkola, I. Cascone, K. Alitalo, and F. Bussolino. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi s sarcoma cells.J Biol Chem274:27617 (1999).

    Article  PubMed  Google Scholar 

  34. M. Clauss, M. Gerlach, H. Gerlach, J. Brett, F. Wang, P.C. Familetti, Y.C.E. Pan, J.V. Olander, D.T. Connolly, and D. Stem. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.J Exp Med172:1535 (1990).

    Article  CAS  PubMed  Google Scholar 

  35. H. Shen, M. Clauss, J. Ryan, A.M. Schmidt, P. Tijburg, L. Borden, D. Connolly, D. Stem, and J. Kao. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.Blood81:2767 (1993).

    CAS  PubMed  Google Scholar 

  36. M. Clauss, H. Weich, G. Breier, U. Knies, W. Röckl, J. Waltenberger, and W. Risau. The vascular endothelial growth factor receptor Flt-1 mediates biological activities.J Biol Chem271:17629 (1996).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic/Plenum Publishers

About this chapter

Cite this chapter

Hamrah, P., Zhang, Q., Dana, M.R. (2002). Expression of Vascular Endothelial Growth Factor Receptor-3 (Vegfr-3) in the Conjunctiva-A Potential Link Between Lymphangiogenesis and Leukocyte Trafficking on the Ocular Surface. In: Sullivan, D.A., Stern, M.E., Tsubota, K., Dartt, D.A., Sullivan, R.M., Bromberg, B.B. (eds) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Advances in Experimental Medicine and Biology, vol 506. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0717-8_120

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0717-8_120

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5208-2

  • Online ISBN: 978-1-4615-0717-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics